ADJUPANRIX

This brand name is authorized in Austria, Croatia, Estonia, Ireland, Lithuania, Poland, Singapore.

Active ingredients

The drug ADJUPANRIX contains one active pharmaceutical ingredient (API):

1	A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14)
	Read more about Influenza, inactivated, split virus

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ADJUPANRIX Emulsion for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07BB02	Influenza, purified antigen	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1451180
LT	Valstybinė vaistų kontrolės tarnyba	1051384
PL	Rejestru Produktów Leczniczych	100308539
SG	Health Sciences Authority	15239P